title: The D prefix: toward a reproducible validated alternative end point in rectal cancer.
authors.affiliation: Middlesex, United Kingdom Leeds, United Kingdom.
authors.forename: Rob
authors.initials: R
authors.lastname: Glynne-Jones
authors.forename: Nicholas P
authors.initials: NP
authors.lastname: West
authors.forename: Philip
authors.initials: P
authors.lastname: Quirke
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D059186:Chemoradiotherapy, Adjuvant; D002986:Clinical Trials as Topic / Q000592:standards; D003107:Colorectal Surgery / Q000379:methods; D006801:Humans; D009367:Neoplasm Staging; D012004:Rectal Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D012074:Remission Induction; D015203:Reproducibility of Results; D016019:Survival Analysis; D054928:Validation Studies as Topic